학술논문

182P Efficacy and tolerability of neratinib in advanced HER-2 positive breast cancer: A single institution experience.
Document Type
Article
Source
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Subject
*HORMONE receptor positive breast cancer
*BREAST cancer
*CELL imaging
Language
ISSN
0923-7534